ALK-ABELLÓ A/S
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-05-04
Analyst
Nordia
Equibles does not estimate personal net worth.
Peter Hugriff is recorded as Analyst at Nordia. Peter Hugriff has spoken on 1 earnings call across 1 company, most recently for ALK-ABELLÓ A/S on May 4, 2026. The companies whose calls Peter Hugriff spoke on are classified in the Healthcare sector.
“Just a few, if I may, maybe for you, Klaus, around margins. You're guiding around, and now we start seeing 26, and maybe even moving upwards, how should we think about 2026 and beyond in terms of the margin development?”
Nordia
Analyst
Transcript header (unverified)
ALK-ABELLÓ A/S
Biotechnology · Healthcare
Three-month interim report (Q1) 2026
ALK-ABELLÓ A/S